series-c-plus
Stage
2018
Founded
1
Investors
About
Visterra is a biologics research and early-stage clinical development company developing therapies for patients with immune-mediated and other hard-to-treat diseases.
Explore Visterra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.